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SI Text
Nomenclature for Populations and Clones Isolated Through Library
Screens. The naïve saturation mutagenesis library was con-
structed using the plasmid pAJL-20, which allows the constitu-
tive expression of wild-type MetRS, as a template. The set of
plasmids obtained by the introduction of the library into
pAJL-20 is designated pAJL-20-LYH.1.0. The population of
clones produced by the transformation of pAJL-20-LYH.1.0 into
the expression host M15MA[pREP4] is referred to as LYH.1.0.
Several screens were applied to LYH.1.0, giving rise to
different cell populations. Names and descriptions of these
populations are listed below. With the exception of LYH.6.2, all
populations were obtained by screening LYH.1.0 in one or more
rounds for clones exhibiting the highest f luorescence labeling.
LYH.1.0. Population carrying the naïve library (Fig. 3A)
LYH.1.1a. The naïve library screened at 1.0 mM Anl
LYH.1.2. LYH.1.1a screened at 1.0 mM Anl (Fig. 3B)
LYH.2.1b. The naïve library screened at 0.1 mM Anl
LYH.2.2. LYH.2.1b screened at 0.1 mM Anl (Fig. 3D)
LYH.2.3. LYH.2.2 screened at 0.1 mM Anl
LYH.3.1. The naïve library screened at 0.3 mM Anl
LYH.3.2. LYH.3.1 screened at 0.3 mM Anl (Fig. 3C)
LYH.3.3. LYH.3.2 screened at 0.3 mM Anl
LYH.4.3. LYH.3.2 screened at 0.1 mM Anl
LYH.5.3c. Mixture of LYH.1.1a, LYH.2.1b, and LYH.3.1
screened for two rounds at 1.0 mM Anl and 0.03
to 0.1 mM Met
LYH.5.3d. The naïve library screened at 1.0 mMAnl and 0.01
to 0.1 mM Met for three rounds (Fig. 3E)
LYH.5.4b. Mixture of LYH.1.1a, LYH.2.1b, and LYH.3.1
screened for three rounds at 0.3 mM Anl and 0.01
to 0.03 mM Met
LYH.6.2. Result of sorting a section of the population on the
low-fluorescence arm of LYH.1.1a
Individual clones isolated from these populations were rean-
alyzed by flow cytometry to determine the extent of cell-surface
labeling supported by the MetRS mutants they carry. The
pAJL-20 variant isolated from each clone is named based on the
MetRSmutant it codes for, such that the plasmid pAJL-20-GML
bears the gene for the MetRS-GML mutant. Variants of
pAJL-61 and pMTY21 used in this study were named similarly.
Among the MetRS variants isolated from the populations
listed above, mutants that enable the incorporation of Anl at 1.0
mM concentration are presented and the populations that
yielded each mutant are listed in Table S2. Mutants discussed in
the main article are indicated in bold face.
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Fig. S1. Effect of the duration of OmpC expression on cell viability and cell-surface labeling. Aliquots were taken from cultures expressing either OmpC or
mDHFR inmedia containing either Anl orMet at different times during protein expression. After cell-surface labeling, cellswere plated on agar and the resulting
colonies were counted to determine the number of viable cells. (A) Counts of viable colonies during expression. Data fromOmpC- andDHFR- expressing cultures
are markedwith filled triangles (Œ) and open diamonds ({), respectively. Data fromAnl-treated cultures are shown in red. No viable colonies could be observed
for cultures that expressed OmpC for 2 h or more. Data were extrapolated beyond 1 h to emphasize this fact. Results suggest that the toxicity due to OmpC
expressionmarkedly decreases cell viability. (B) Total cell fluorescence at different times duringOmpCexpression. Aliquots takenduring protein expressionwere
fluorescently labeled and their total cell fluorescence was determined. Data are shown relative to the fluorescence read from uninduced cells. The fluorescence
labeling is near complete after only 0.5 h of OmpC expression.
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Fig. S2. Extent of fluorescence labeling at different Anl concentrations on cells expressing various MetRS mutants. OmpC expression was carried out in M9
19aa media supplemented with 0.03, 0.01, 0.3, 1.0, or 3.0 mM Anl. Median fluorescence of the labeled cell population was determined by flow cytometry. The
median fluorescence for cells treated at each Anl concentration (red circles), and the Hill equation fit to the data (red lines) are displayed for eachMetRSmutant
tested. In cases where a fluorescence drop was observed going from 1.0 to 3.0 mMAnl, the final data point was not included in equation fitting. The EC50 value
obtained from the Hill equation is indicated on each plot in millimolar units. Mutants selected at 0.3 mM Anl (labeled in blue) exhibit lower EC50 values than
mutants selected at 1.0 mM Anl (labeled in green).
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Fig. S3. Unmodified images of SDS/PAGE gels of cell lysates showing mDHFR synthesis at various expression conditions. Expression of mDHFR was performed
in M15MA[pREP4/pAJL-61] cells encoding the MetRS mutants obtained from screens carried out at 0.3 mM and 1.0 mM Anl, and the L13G mutant. Cells grown
to midlog phase in M9  20aa medium were then shifted into M9  19aa medium (no Met) supplemented with either 0.1, 0.3, or 1.0 mM Anl (lanes 2, 3 and
4, respectively), 40 mg/L Met (lane 5), or no 20th amino acid (lane 1) before induction of mDHFR synthesis. Cell aliquots obtained before induction are shown
in lane 0. Mark12 (Invitrogen) ladder was used in all gels (lane L). mDHFR has a molecular mass of 24.0 kDa.
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Fig. S4. MALDI-MS analysis of tryptic peptides from mDHFR expressed at varying concentrations of Anl in cells bearing MetRS mutants. Expression of mDHFR
was performed in M15MA[pREP4/pAJL-61] cells encoding the MetRS mutants obtained from screens carried out at 0.3 mM and at 1.0 mM Anl, and the L13G
mutant. Expression was performed in M9  19aa (no Met) media supplemented with either 0.1, 0.3, or 1.0 mM Anl, 40 mg/L Met, or no 20th amino acid. The
expressed mDHFR was purified, and its tryptic digests were analyzed by MALDI-MS. The peaks belonging to the tryptic fragment IMQEFESDTFFPEIDLGKYK
(2,437.16 Da) are shown in the range 2,425–2,475 Da. Replacement of Met by Anl results in a 23.05 Da increase in peptide mass. The expected locations of the
Met- and Anl-containing peptides are marked on the spectra by green and red lines, respectively. Consistent with SDS/PAGE (Fig. 4B and Fig. S3), theMALDI-MS
data shows that mutants selected at 0.3 mM Anl (labeled in blue) allow near complete replacement of Met by Anl at 0.3 mM Anl, whereas little or no Anl
incorporation was observed at this concentration with mutants selected at 1.0 mM Anl (labeled in green). In the absence of Met and at low Anl concentrations
the L13Gmutant permits the incorporation of an alternate amino acid 3 Da lighter thanMet. Such amass shift corresponds to the natural amino acids glutamine
or lysine. Identical incorporation patterns were observed when the mass of an alternate tryptic peptide (QNLVINGR; 930.52 Da) was monitored.
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Fig. S5. Distribution of the selected mutations across the randomized sites on MetRS. From 162 active clones isolated through screening the naïve library, 41
distinct MetRS mutants that show activity toward Anl were identified (Table S2). Distribution of mutations observed at each randomized site among the 41
mutants is displayed. Substituted residues at each site are ordered by decreasing hydrophobicity according to the Kyte-Doolittle scale [Kyte J, Doolittle RF (1982)
J Mol Biol 157:105–132]. Based on this scale, residues are grouped as hydrophobic (1.0; shades of yellow) or hydrophilic (2.0; shades of blue). Residues that
rank between these two groups are shown in shades of green. Mutation distributions compiled (A) from all distinct mutants (n  41) isolated, and (B) from
mutants (n 13) observed in high stringency screens (0.3mMAnl or better) are displayed. Results show thatmutations to aliphatic nonpolar residues at positions
260 and 301 are compatible with Anl activity. In contrast, small residues with more hydrophilic character are preferred at position 13.
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Table S1. Kinetic parameters for the activation of Anl and Met by the MetRS variants identified in this study and the L13G mutant
MetRS EC50, mM
Anl activation Met activation
Selectivity†Km, mM kcat, s1 kcat/Km, M1 s1 kcat/Km, rel* Km, mM kcat, s1 kcat/Km, M1 s1 kcat/Km, rel*
wt‡ - - - - - 0.024 13.30 550,000 1 -
L13G 0.39 5.1  1.3 0.85  0.07 170  40 1:3,200 0.16  0.06 0.87  0.18 5,600  1,500 1:92 0.03
PLL - 1.5  0.7 0.92  0.22 650  150 1:850 5.3  1.9 1.0  0.2 200  50 1:2,700 3.2
NLL 0.17 2.2  0.8 0.87  0.11 410  80 1:1,400 2.6  0.5 0.86  0.07 350  70 1:1,600 1.2
SLL 0.17 4.2  1.1 0.90  0.13 220  20 1:2,600 1.0  0.3 0.89  0.16 900  80 1:610 0.24
CLL 0.07 2.0  0.7 0.98  0.16 520  120 1:1,100 0.14  0.04 0.94  0.18 7,100  600 1:77 0.07
PLI - 2.4  1.0 0.89  0.18 410  140 1:1,300 - - - - -
PIL 0.15 6.6  1.8 0.84  0.08 130  40 1:4,100 - - - - -
PNL 0.27 5.3  2.2 0.47  0.10 98  37 1:5,600 - - - - -
GML 0.29 11  5 0.48  0.11 47  13 1:12,000 - - - - -
GIL 0.31 15  3 0.22  0.01 14  3 1:38,000 - - - - -
GCL 0.52 12  3 0.12  0.01 11  2 1:51,000 - - - - -
*Relative to kcat/Km of the wild-type enzyme for Met.
†Selectivity is defined as the ratio of kcat/Km for Anl to that for Met.
‡Activation parameters for wild-type MetRS are taken from ref. 1.
1. Kiick KL, Tirrell DA (2000) Protein engineering by in vivo incorporation of non-natural amino acids: Control of incorporation of methionine analogues by methionyl-tRNA synthetase.
Tetrahedron 56:9487–9493.
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Table S2. MetRS mutants identified through library screening to allow Anl incorporation at 1.0 mM concentration in vivo
Occurrence L13 Y260 H301 Populations from which clones were isolated*
62† N L L 2.2, 2.3, 3.2, 3.3, 4.3, 5.3c, 5.3d, 5.4b
14†‡ P L L 2.2, 2.3, 5.3c, 5.3d
12† S L L 2.2, 2.3, 3.2, 5.4b
9† P L I 2.2, 5.3c, 5.4b
5 P N L 1.2, 3.3, 4.3
4 G M L 1.2
4 G T L 1.2, 3.3, 6.2
4 G V L 6.2
4† S M L 3.2, 3.3
3 A V L 6.2
3 G I L 1.2
3† G N L 3.2, 3.3, 4.3
2 A Q L 1.2, 6.2
2† C L L 3.2
2 G C L 1.2
2† G L L 3.2, 5.3d
2 P N V 6.2
2 S S L 6.2
1 A C L 1.2
1 C V L 1.2
1 D L I 1.2
1 F G L 6.2
1 F V L 3.3
1 G L V 6.2
1 H C L 1.2
1 H T M 1.2
1 L C L 6.2
1 M A L 1.2
1 M S L 6.2
1 N V L 1.2
1† P C L 3.2
1† P I L 3.2
1 P I M 1.2
1† P L V 3.2
1† P M L 2.2
1 P T V 1.2
1† P V L 5.3d
1 S C M 6.2
1 S L V 4.3
1 S N L 6.2
1 S T L 1.2
162 Total
Mutants discussed in the main article are shown in bold.
*The identifiers for the populations are listed (e.g., population ‘‘2.2’’ refers to LYH.2.2).
†These 13 mutants were observed in high stringency screens (0.3 and 0.1 mM Anl screens and screens against Met).
‡Count also includes 12 clones carrying MetRS-PLL with the additional H98N surface mutation.
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Table S3. Primers used in this study
Primer name Sequence
Primers used in library construction
Lib_fwd2 CTCAGTACCAGTTCGACTTCGGTCTGCGTCCGTCCCTG
L13_lib2-r GATTGAGCCGTTAGCGTACGGMNNTGCGCACGTCACCAG
L13_lib3 GAAAATTCTGGTGACGTGCGCANNKCCGTACGCTAACGGCTCA
Y260_lib3-r CTTGAAAGAACCCATMNNGCCAATCGGTGCGTCCAGC
Y260_lib3 GCTGGACGCACCGATTGGCNNKATGGGTTCTTTCAAG
H301_lib3-r CAGCATGGCAGGCCAGAACAGGCTMNNGAAGTAAACAATATC
H301_lib2 GATATTGTTTACTTCNNKAGCCTGTTCTGGCCTGCCATGC
lib_rev2 CAGTACCGGCTTCAGGTAAGTCATCAGCACGCGGAAC
lib_fwd3 CAGTACCAGTTCGACTTCGGTCTGCGTC
lib_rev3 CTTCAGGTAAGTCATCAGCACGCGGAAC
Primers used in the construction of pMTY21 variants
MRS_BamHI TTCCGCGGATCCATGACTCAAGTCGCGAAGAAAATTC
MRS_SalI-r TTTGGGGTCGACTCATTTAGAGGCTTCCACCAGTG
Site directed mutagenesis primers
eM_L13G CTGGTGACGTGCGCAGGTCCGTACGCTAACGGCTC
eM_G13C ATTCTGGTGACGTGCGCATGTCCGTACGCTAAC
eM_G13N ATTCTGGTGACGTGCGCAAACCCGTACGCTAAC
eM_G13P ATTCTGGTGACGTGCGCACCGCCGTACGCTAAC
eM_G13S ATTCTGGTGACGTGCGCAAGCCCGTACGCTAAC
eM_Y260C GACGCACCGATTGGCTGCATGGGTTCTTTCAAG
eM_Y260I GGACGCACCGATTGGCATCATGGGTTCTTTCAAG
eM_Y260L GGACGCACCGATTGGCCTGATGGGTTCTTTCAAG
eM_Y260M GGACGCACCGATTGGCATGATGGGTTCTTTCAAG
eM_Y260N GGACGCACCGATTGGCAACATGGGTTCTTTCAAG
eM_H301L GATATTGTTTACTTCCTGAGCCTGTTCTGGCCTGC
For mixed nucleotides, N A, T, G, C, K G, T andM C, A. Only the forward sequence is provided for site-directed mutagenesis primers. All sequences are
listed in the 5-to-3 direction. Mutation sites are indicated in bold.
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